Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 publications

Deutsch | English | Español | Français | Italiano | Português; | Tiếng Việt | Türkçe


  Hepatitis

  Free Subscription


25.05.2020

1 Am J Gastroenterol
1 Clin Infect Dis
2 Dig Dis Sci
1 Gastroenterology
1 Hepatology
1 Int J Cancer
1 J Infect Dis
2 J Med Virol
1 J Viral Hepat
1 J Virol
2 Lancet Gastroenterol Hepatol
1 Lancet Infect Dis
1 MMWR Morb Mortal Wkly Rep
2 N Engl J Med
4 PLoS One
1 PLoS Pathog
1 Proc Natl Acad Sci U S A
1 Transplantation


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Gastroenterol

  1. POLANCO NP, Goldberg D
    Transplanting Livers From "HCV-Positive" Donors To HCV-Negative Recipients: Increased Experience But Many Unanswered Questions.
    Am J Gastroenterol. 2020 May 20. doi: 10.14309/ajg.0000000000000649.
    PubMed         Abstract available


    Clin Infect Dis

  2. VALERIO H, Alavi M, Silk D, Treloar C, et al
    Progress towards elimination of hepatitis C infection among people who inject drugs in Australia: The ETHOS Engage Study.
    Clin Infect Dis. 2020 May 18. pii: 5838577. doi: 10.1093.
    PubMed         Abstract available


    Dig Dis Sci

  3. DOSHI SD, Stotts MJ, Hubbard RA, Goldberg DS, et al
    The Changing Burden of Alcoholic Hepatitis: Rising Incidence and Associations with Age, Gender, Race, and Geography.
    Dig Dis Sci. 2020 May 20. pii: 10.1007/s10620-020-06346.
    PubMed         Abstract available

  4. MCNALLY BB, Carey EJ
    Azathioprine Monotherapy Is Equivalent to Dual Therapy in Maintaining Remission in Autoimmune Hepatitis.
    Dig Dis Sci. 2020 May 20. pii: 10.1007/s10620-020-06347.
    PubMed         Abstract available


    Gastroenterology

  5. LIAW YF
    Stopping nucleos(t)ide analogue therapy in HBeAg-negative chronic hepatitis B.
    Gastroenterology. 2020 May 17. pii: S0016-5085(20)30672.
    PubMed        


    Hepatology

  6. FRANCA A, Filho ACML, Guerra MT, Weerachayaphorn J, et al
    Effects of endotoxin on type 3 inositol 1,4,5-trisphosphate receptor in human cholangiocytes.
    Hepatology. 2018 Aug 23. doi: 10.1002/hep.30228.
    PubMed         Abstract available


    Int J Cancer

  7. PARKIN DM, Hammerl L, Ferlay J, Kantelhardt EJ, et al
    Cancer in Africa 2018: the role of infections.
    Int J Cancer. 2019 Jun 29. doi: 10.1002/ijc.32538.
    PubMed         Abstract available


    J Infect Dis

  8. RONG G, Chen Y, Yu Z, Li Q, et al
    Synergistic Effect of Biejia-Ruangan on Fibrosis Regression in Patients with Chronic Hepatitis B Treated with Entecavir: A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial.
    J Infect Dis. 2020 May 21. pii: 5841650. doi: 10.1093.
    PubMed         Abstract available


    J Med Virol

  9. WAHID B, Shami K, Joiya SA, Ozuyar SEG, et al
    Comparing the risk of hypothyroidism in HCV patients treated with different DAA drugs combinations (sofosbuvir + interferon + ribavirin and sofosbuvir + daclatasvir + ribavirin).
    J Med Virol. 2020 May 17. doi: 10.1002/jmv.25931.
    PubMed         Abstract available

  10. LIU Y, Zhao ZH, Lv XQ, Tang YW, et al
    Precise analysis of the effect of basal core promoter/precore mutations on the main phenotype of chronic hepatitis B in mouse models.
    J Med Virol. 2020 May 19. doi: 10.1002/jmv.26025.
    PubMed         Abstract available


    J Viral Hepat

  11. DE LEDINGHEN V, Lusivika-Nzinga C, Bronowicki JP, Zoulim F, et al
    Sofosbuvir-based regimens are suboptimal in patients with genotype 2 chronic hepatitis C infection: Real-life experience from the HEPATHER ANRS CO22 cohort.
    J Viral Hepat. 2020 May 21. doi: 10.1111/jvh.13321.
    PubMed         Abstract available


    J Virol

  12. LAI YT, Liou YM, Hsin F, Liu HM, et al
    Genotypic Regulations of Type I Interferon Induction Pathways by the Frame-Shift (F) Proteins of Hepatitis C Virus.
    J Virol. 2020 May 20. pii: JVI.00312-20. doi: 10.1128/JVI.00312.
    PubMed         Abstract available


    Lancet Gastroenterol Hepatol

  13. MAK LY
    Switching from tenofovir disoproxil fumarate to tenofovir alafenamide: perhaps not as simple as we thought.
    Lancet Gastroenterol Hepatol. 2020 Feb 20. pii: S2468-1253(19)30450.
    PubMed        

  14. THE LANCET GASTROENTEROLOGY HE
    Eliminating HCV: a marathon, not a sprint.
    Lancet Gastroenterol Hepatol. 2020;5:515.
    PubMed        


    Lancet Infect Dis

  15. VAILLANT A
    Should alanine aminotransferase flares mean stopping antiviral therapy in patients with cirrhosis?
    Lancet Infect Dis. 2019;19:221-222.
    PubMed        


    MMWR Morb Mortal Wkly Rep

  16. HOFMEISTER MG, Foster MA, Montgomery MP, Gupta N, et al
    Notes from the Field: Assessing the Role of Food Handlers in Hepatitis A Virus Transmission - Multiple States, 2016-2019.
    MMWR Morb Mortal Wkly Rep. 2020;69:636-637.
    PubMed        


    N Engl J Med

  17. CASADIO L, Nastri AC, Malta FM, Araujo J, et al
    Late-Onset Relapsing Hepatitis Associated with Yellow Fever.
    N Engl J Med. 2020;382:2059-2061.
    PubMed        

  18. CHANCELLOR JR, Sallam AB
    Fungal Endophthalmitis.
    N Engl J Med. 2020;382:e48.
    PubMed        


    PLoS One

  19. ISMAIL MB, Al Kassaa I, El Safadi D, Al Omari S, et al
    Prevalence of anti-hepatitis E virus IgG antibodies in sera from hemodialysis patients in Tripoli, Lebanon.
    PLoS One. 2020;15:e0233256.
    PubMed         Abstract available

  20. POILIL SURENDRAN S, George Thomas R, Moon MJ, Park R, et al
    Effect of hepato-toxins in the acceleration of hepatic fibrosis in hepatitis B mice.
    PLoS One. 2020;15:e0232619.
    PubMed         Abstract available

  21. NGUYEN DT, Tran TTT, Nghiem NM, Le PT, et al
    Effectiveness of sofosbuvir based direct-acting antiviral regimens for chronic hepatitis C virus genotype 6 patients: Real-world experience in Vietnam.
    PLoS One. 2020;15:e0233446.
    PubMed         Abstract available

  22. RUIZ-EXTREMERA A, Diaz-Alcazar MDM, Munoz-Gamez JA, Cabrera-Lafuente M, et al
    Seroprevalence and epidemiology of hepatitis B and C viruses in pregnant women in Spain. Risk factors for vertical transmission.
    PLoS One. 2020;15:e0233528.
    PubMed         Abstract available


    PLoS Pathog

  23. JU X, Xiang G, Gong M, Yang R, et al
    Identification of functional cis-acting RNA elements in the hepatitis E virus genome required for viral replication.
    PLoS Pathog. 2020;16:e1008488.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  24. VERMA M, Chu JN, Salama JAF, Faiz MT, et al
    Development of a long-acting direct-acting antiviral system for hepatitis C virus treatment in swine.
    Proc Natl Acad Sci U S A. 2020 May 18. pii: 2004746117.
    PubMed         Abstract available


    Transplantation

  25. BAE S, Durand CM, Garonzik-Wang JM, Chow EKH, et al
    Antithymocyte Globulin Versus Interleukin-2 Receptor Antagonist in Kidney Transplant Recipients With Hepatitis C Virus.
    Transplantation. 2020;104:1294-1303.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: